To further analyze the power of GM-CSF in predicting pregnancy outcomes, ROC curve analyses of MS, GM-CSF, and combined indicator with MS and GM-CSF (Combination) for predicting HP, CP, and OP were performed, respectively (Figure 1). This evidence concerns the gene CSF2 and myeloid sarcoma.